Brokerages Set Azenta, Inc. (NASDAQ:AZTA) PT at $35.75

Azenta, Inc. (NASDAQ:AZTAGet Free Report) has earned an average recommendation of “Hold” from the seven brokerages that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $36.20.

A number of research analysts have issued reports on AZTA shares. Evercore ISI set a $33.00 target price on shares of Azenta and gave the company an “in-line” rating in a research report on Tuesday, August 5th. Jefferies Financial Group upgraded shares of Azenta from a “hold” rating to a “buy” rating and upped their target price for the company from $30.00 to $38.00 in a research report on Thursday. Weiss Ratings restated a “sell (d-)” rating on shares of Azenta in a research report on Wednesday, October 8th. Stephens started coverage on shares of Azenta in a research report on Tuesday, July 22nd. They set an “equal weight” rating and a $35.00 target price on the stock. Finally, Raymond James Financial upgraded shares of Azenta from a “market perform” rating to an “outperform” rating and set a $35.00 target price on the stock in a research report on Wednesday, August 6th.

Read Our Latest Stock Analysis on AZTA

Institutional Trading of Azenta

A number of hedge funds have recently modified their holdings of AZTA. Dynamic Technology Lab Private Ltd bought a new stake in Azenta during the 1st quarter worth approximately $505,000. Nordea Investment Management AB increased its stake in Azenta by 31.7% during the 2nd quarter. Nordea Investment Management AB now owns 149,200 shares of the company’s stock worth $4,566,000 after purchasing an additional 35,874 shares in the last quarter. Exchange Traded Concepts LLC increased its stake in Azenta by 44.2% during the 2nd quarter. Exchange Traded Concepts LLC now owns 417,597 shares of the company’s stock worth $12,854,000 after purchasing an additional 128,084 shares in the last quarter. Kera Capital Partners Inc. bought a new stake in Azenta during the 2nd quarter worth approximately $321,000. Finally, Stephens Investment Management Group LLC increased its stake in Azenta by 0.4% during the 2nd quarter. Stephens Investment Management Group LLC now owns 807,173 shares of the company’s stock worth $24,845,000 after purchasing an additional 3,372 shares in the last quarter. 99.08% of the stock is currently owned by institutional investors and hedge funds.

Azenta Trading Up 1.8%

Azenta stock opened at $30.73 on Tuesday. Azenta has a 1 year low of $23.91 and a 1 year high of $55.63. The company has a market cap of $1.41 billion, a PE ratio of -12.70 and a beta of 1.62. The company’s 50-day moving average is $30.60 and its two-hundred day moving average is $29.93.

Azenta (NASDAQ:AZTAGet Free Report) last released its earnings results on Tuesday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.13 by $0.06. Azenta had a negative net margin of 18.45% and a positive return on equity of 1.35%. The company had revenue of $143.94 million for the quarter, compared to the consensus estimate of $149.64 million. During the same period in the prior year, the company posted $0.14 EPS. The company’s revenue was up .0% compared to the same quarter last year. Research analysts forecast that Azenta will post 0.53 EPS for the current year.

Azenta Company Profile

(Get Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Featured Stories

Analyst Recommendations for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.